PreprintAll rights reservedmedRxiv
A Drug-Specific, Half-Life-Adjusted Framework for Classifying CNS-Active Systemic Therapy Exposure During and After Radiotherapy
- 1UT Southwestern Medical Center
Related
- Sex-specific associations between weight-adjusted waist index and peak expiratory flow in middle-aged and older Chinese adults: a cross-sectional study from CHARLS
- Nanoparticle-Enabled Immune-Dose Shaping in Breast Cancer Radiotherapy: Reconciling Tumor Immunogenicity with Systemic Immune Preservation
- Multi-Cycle Dosimetry of the Albumin-Binding Prostate-Specific Membrane Antigen Ligand [¹⁷⁷Lu]Ludotadipep in Metastatic Androgen Pathway Modulator-Resistant Prostate Cancer with Adjusted Red Marrow Modeling.
- An Integrated Framework for Classifying Intervention Mechanisms and Measurement Methodologies of Lower-Limb Proprioception in Patients with Stroke: A Systematic Review and Exploratory Meta-Analysis
- The Predictive Value of the Systemic Immune‐Inflammation Index Combined With Clinical Stage for the Prognosis of Oesophageal Cancer Patients Treated With Radiotherapy: A Retrospective Cohort Study and Meta‐Analysis
BibTeX
@misc{mitre2026drugspecific,
title = {{A Drug-Specific, Half-Life-Adjusted Framework for Classifying CNS-Active Systemic Therapy Exposure During and After Radiotherapy}},
author = {L. Pari Mitre and B. Drapkin and M. Dohopolski},
howpublished = {medRxiv},
year = {2026},
month = jun,
doi = {10.64898/2026.06.11.26354463},
url = {https://www.medrxiv.org/content/10.64898/2026.06.11.26354463v3},
}
RIS
TY - UNPB
TI - A Drug-Specific, Half-Life-Adjusted Framework for Classifying CNS-Active Systemic Therapy Exposure During and After Radiotherapy
AU - L. Pari Mitre
AU - B. Drapkin
AU - M. Dohopolski
PY - 2026
DA - 2026/06/11
PB - medRxiv
DO - 10.64898/2026.06.11.26354463
UR - https://www.medrxiv.org/content/10.64898/2026.06.11.26354463v3
ER -